Key Insights

Highlights

Success Rate

100% trial completion (above average)

Research Leaders

7 sponsors active, led by Centre d'Infection et d'Immunité de Lille

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT01553552Completed

Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern Senegal

Showing all 1 trials

Research Network

Active Sponsors

  • Centre d'Infection et d'Immunité de Lille1
  • Institut National de la Santé Et de la Recherche Médicale, France1
  • Centre National de la Recherche Scientifique, France1
  • Institut Pasteur de Lille1
  • Région Nord-Pas de Calais, France1

Top Investigators

Related Conditions

  • Anemia1
  • Schistosomiasis1
  • Stunting1
  • Underweight1

Activity Timeline